NCT06903975 BoTox Into the Sternocleidomastoid Muscles (SCM)
| NCT ID | NCT06903975 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Boston Medical Center |
| Condition | Neck Muscle Issue |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-05-14 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 30 participants in total. It began in 2025-05-14 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.
Eligibility Criteria
Inclusion Criteria: * Age eligible individual seeking a more feminine neck appearance Exclusion Criteria: * Prior neuromodulator injections in the sternocleidomastoid muscles (SCM) within the past year * Current anticoagulant use * Body mass index (BMI) \>30 * Anticipation of significant weight gain or loss during the study period (e.g. patients taking or planning to take within the study period a semaglutide medication.) * Prior allergy to botulinum toxin A * Currently pregnant or breastfeeding
Contact & Investigator
Jeffrey Spiegel, MD
PRINCIPAL INVESTIGATOR
Boston Medical Center and The Spiegel Center
Frequently Asked Questions
Who can join the NCT06903975 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Neck Muscle Issue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06903975 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06903975 currently recruiting?
Yes, NCT06903975 is actively recruiting participants. Contact the research team at Jeffrey.Spiegel@bmc.org for enrollment information.
Where is the NCT06903975 trial being conducted?
This trial is being conducted at Newton, United States.
Who is sponsoring the NCT06903975 clinical trial?
NCT06903975 is sponsored by Boston Medical Center. The principal investigator is Jeffrey Spiegel, MD at Boston Medical Center and The Spiegel Center. The trial plans to enroll 30 participants.